US pharmaceutical company Eli Lilly and Company will invest more than $1 billion in new contract manufacturing operations in India, with a major manufacturing and quality facility to be established in Hyderabad, reported by ANI. The multi-year investment aims to expand global access to Lilly's medicines and strengthen its supply capabilities, marking one of the largest commitments by a global drugmaker in India in recent years.

Major expansion for Hyderabad's pharma ecosystem

The announcement came after a delegation from Eli Lilly met Telangana Chief Minister A Revanth Reddy and Industries Minister D Sridhar Babu at the Integrated Command and Control Centre in Hyderabad on Monday, October 6. The company's decision reinforces Hyderabad's growing position as a leading life sciences and pha

See Full Page